The findings presented above suggest that modulating VDAC1 expression levels or its apoptotic activity are possible strategies to either activate apoptosis in cancer or inhibit apoptosis in CVDs, AD and T2D. This evidence concerns the gene VDAC1 and type 2 diabetes mellitus.